UK’s medicines licensing agency has cleared the way for a brand of e-cigarette to be marketed as a quit-smoking aid.
British American Tobacco, the makers of the e-Voke, won approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), meaning the device could eventually be prescribed on the NHS in the same way as other Nicotine Replacement Therapy.
“The MHRA has licenced this product as a medicine, which removes a barrier to it being prescribed by medical practitioners as part of a quit attempt, like other Nicotine Replacement Therapy,” said George Butterworth, tobacco control manager at Cancer Research UK.
While early research suggests that e-cigarettes could prove a worthwhile aid in the fight to eradicate the single biggest preventable cause of cancer worldwide – opinion is still divided on their long-term safety.
Read the full news report via Cancer Research UK